The PBS-approved indication for budesonide/formoterol (Symbicort Turbuhaler 200/6 and Rapihaler 100/3) has now been extended to include as-needed management of patients 12 years and over with mild asthma. The change is in line with an early update to the Australian Asthma Handbook – yet to be endorsed by the TSANZ or the RACGP – and ...
As-needed ICS now available on PBS for mild asthma
By Mardi Chapman
2 Jun 2020